Back to mobile site

More on VTRS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-1.6% Growth)
- Ratings (3.8 Score)
- Holders
- Dividends (2.9% Yield)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Viatris Inc (NQ:VTRS)
Delayed: 16.70 +0.52 (3.21%)
Prev. Close $16.18  
Open$16.28 
52 Wk High$ 
52 Wk Low$ 
Day High$16.74 
Day Low$16.27 
P/E N/A  
EPS$ 
Volume9,348,064 

Friends, Peers and Foes (?): LXRX, AMRX, TEVA SLGL (more...)

Jul 1, 2026 06:02 PM Form 4 Viatris Inc For: Jun 30 Filed by: SIMMONS DAVID S
Jul 1, 2026 06:00 PM Form 4 Viatris Inc For: Jun 30 Filed by: Groothuis Leo Frans
Jul 1, 2026 04:24 PM Viatris refinances ¥40 billion Japanese yen term loan facility
Jul 1, 2026 04:21 PM Form 8-K Viatris Inc For: Jul 01
Jul 1, 2026 06:59 AM Viatris to Report Second-Quarter 2026 Financial Results on August 6, 2026
Jun 29, 2026 06:59 AM Viatris Phase 3 Japan trial of kidney drug VR-205 meets primary endpoint
Jun 29, 2026 06:59 AM Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
Jun 26, 2026 05:00 PM Form 4 Viatris Inc For: Jun 25 Filed by: Campbell Paul
Jun 26, 2026 08:20 AM Viatris (VTRS) PT Raised to $119 at Morgan Stanley
Jun 25, 2026 04:28 PM Form 144 Viatris Inc Filed by: Campbell Paul
View All Articles

Entities mentioned with VTRS

View All Entities